{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:47:14Z","timestamp":1778672834318,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejmech.2020.112405","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:32:34Z","timestamp":1589769154000},"page":"112405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Design, synthesis and biological evaluation of 7-substituted 4-phenyl-6H-imidazo[1,5-a]thieno[3,2-f] [1,4]diazepines as safe anxiolytic agents"],"prefix":"10.1016","volume":"200","author":[{"given":"Angela","family":"Di Capua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Reale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Paolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Chemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fedora","family":"Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Matucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Anzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112405_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euroneuro.2009.01.011","article-title":"Research in anxiety disorders: from the bench to the bedside","volume":"19","author":"Garner","year":"2009","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejmech.2020.112405_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112405_bib3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1176\/ajp.152.8.1228","article-title":"Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV)","volume":"152","author":"Guze","year":"1995","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejmech.2020.112405_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2020.112405_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.25149\/1756-8358.1102013","article-title":"Treating anxiety with either beta blockers or antiemetic antimuscarinic drugs: a Review","volume":"11","author":"Dooley","year":"2015","journal-title":"Ment. Health Fam. Med."},{"key":"10.1016\/j.ejmech.2020.112405_bib6","series-title":"Handb. Anxiety Fear","first-page":"395","article-title":"Chapter 5.2 How effective are current drug treatments for anxiety disorders, and how could they be improved?","author":"Baldwin","year":"2008"},{"key":"10.1016\/j.ejmech.2020.112405_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm00187a001","article-title":"The benzodiazepine story","volume":"22","author":"Sternbach","year":"1979","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal","volume":"28","author":"Dell\u2019osso","year":"2013","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.ejmech.2020.112405_bib9","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2014will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.ejmech.2020.112405_bib10","series-title":"GABA and Benzodiazepine Receptors","author":"Squires","year":"1988"},{"key":"10.1016\/j.ejmech.2020.112405_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bst0320529","article-title":"The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function","volume":"32","author":"Connolly","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2020.112405_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABAA receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2020.112405_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","article-title":"International union of pharmacology. XV. Subtypes of \u03b3-aminobutyric AcidA receptors: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2020.112405_bib14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/346648a0","article-title":"Cerebellar GABAA receptor selective for a behavioural alcohol antagonist","volume":"346","author":"L\u00fcddens","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112405_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112405_bib16","first-page":"349\u2014355","article-title":"Diazepam versus alprazolam for the treatment of panic disorder","volume":"57","author":"Noyes","year":"1996","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.ejmech.2020.112405_bib17","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharm. Times"},{"key":"10.1016\/j.ejmech.2020.112405_bib18","first-page":"165","article-title":"Recent advances in the molecular pharmacology of Benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists","volume":"14","author":"Haefely","year":"1985","journal-title":"Adv. Drug Res."},{"key":"10.1016\/j.ejmech.2020.112405_bib19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3762\/bjoc.14.155","article-title":"Synthesis of new tricyclic 5,6-dihydro-4H-benzo[b][1,2,4]triazolo[1,5-d][1,4]diazepine derivatives by [3+\u00a0+ 2]-cycloaddition\/rearrangement reactions","volume":"14","author":"Luan","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/chin.199332313","article-title":"ChemInform Abstract: benzodiazepines, the story of the antagonist flumazenil and of the partial agonist bretazenil","volume":"24","author":"Hunkeler","year":"1993","journal-title":"ChemInform"},{"key":"10.1016\/j.ejmech.2020.112405_bib21","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/bmj.301.6764.1308","article-title":"Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomised controlled study","volume":"301","author":"H\u00f6jer","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2020.112405_bib22","first-page":"88","article-title":"Molecular and neurochemical evaluation of the effects of etizolam on GABAA receptors under normal and stress conditions","volume":"49","author":"Sanna","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2020.112405_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2165\/00003495-198835020-00002","volume":"35","author":"Langley","year":"1988","journal-title":"Brotizolam, Drugs."},{"key":"10.1016\/j.ejmech.2020.112405_bib24","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1021\/jm8002944","article-title":"Ethyl 8-Fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as novel, highly potent, and Safe antianxiety agent","volume":"51","author":"Anzini","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib25","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1021\/jm2001597","article-title":"New insight into the central benzodiazepine receptor\u2013ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds","volume":"54","author":"Anzini","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib26","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1021\/jm960325j","article-title":"Molecular basis of peripheral vs central benzodiazepine receptor selectivity in a new class of peripheral benzodiazepine receptor ligands related to alpidem","volume":"39","author":"Anzini","year":"1996","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/jm001004h","article-title":"Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors","volume":"44","author":"Matarrese","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib28","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1021\/jm200770f","article-title":"Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold","volume":"54","author":"Cappelli","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib29","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/acs.jmedchem.6b00034","article-title":"Design, synthesis, and biological evaluation of imidazo[1,5-a]quinoline as highly potent ligands of central benzodiazepine receptors","volume":"59","author":"Cappelli","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib30","first-page":"318","article-title":"An insight intomedicinal and biological significance of privileged scaffold: 1,4-Benzodiazepine","volume":"4","author":"Navjeet","year":"2013","journal-title":"Int. J. Pharma Bio Sci."},{"key":"10.1016\/j.ejmech.2020.112405_bib31","series-title":"Privileged Structures in Drug Discovery: Medicinal Chemistry and Synthesis","author":"Yet","year":"2018"},{"key":"10.1016\/j.ejmech.2020.112405_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/cr0200015","article-title":"Thioamides as useful synthons in the synthesis of heterocycles","volume":"103","author":"Jagodzi\u0144ski","year":"2003","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.112405_bib33","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1021\/ja038900d","article-title":"Fluorescent polymeric transducer for the rapid, simple, and specific detection of nucleic acids at the zeptomole level","volume":"126","author":"Dor\u00e9","year":"2004","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112405_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3998\/ark.5550190.0011.105","article-title":"Gewald reaction: synthesis, properties and applications of substituted 2-aminothiophenes","volume":"2010","author":"Puterov\u00e1","year":"2010","journal-title":"Arkivoc"},{"key":"10.1016\/j.ejmech.2020.112405_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ange.19610730307","article-title":"Zur Reaktion von \u03b1-Oxo-mercaptanen mit Nitrilen","volume":"73","author":"Gewald","year":"1961","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/jm010081p","article-title":"2-Amino-3-aroyl-4,5-alkylthiophenes:\u2009agonist allosteric enhancers at human A1 adenosine receptors","volume":"45","author":"Tranberg","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib37","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/jhet.5570280704","article-title":"Synthesis of novel, substituted 4H-imidazo[1,5-a][1,4]benzodiazepines","volume":"28","author":"Fryer","year":"1991","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1254\/jjp.42.189","article-title":"Comparison of typical and atypical benzodiazepines on the central and peripheral benzodiazepine receptors","volume":"42","author":"Watanabe","year":"1986","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112405_bib39","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1471-4159.1982.tb12546.x","article-title":"Benzodiazepine antagonist Ro 15\u20131788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels","volume":"37","author":"M\u00f6hler","year":"1982","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2020.112405_bib40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A\u00a0short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.ejmech.2020.112405_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1471-4159.1982.tb10848.x","article-title":"Isolation of putative benzodiazepine receptors from rat brain membranes by affinity chromatography","volume":"38","author":"Martini","year":"1982","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2020.112405_bib42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF02245629","article-title":"The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety","volume":"121","author":"Walsh","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2020.112405_bib43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00451681","article-title":"Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia","volume":"98","author":"Malcangio","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2020.112405_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2466\/pr0.1967.21.1.221","article-title":"An improved one-trial passive avoidance learning situation","volume":"21","author":"Jarvik","year":"1967","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.ejmech.2020.112405_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-3908(85)90076-0","article-title":"A\u00a0comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen","volume":"24","author":"Vaught","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2020.112405_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(98)00223-4","article-title":"Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and\/or anxiolytic state in mice","volume":"350","author":"Takeda","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112405_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","article-title":"Structure of a human synaptic GABAA receptor","volume":"559","author":"Zhu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112405_bib48","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ejmech.2016.10.064","article-title":"Identification of novel fluorescent probes preventing PrPSc replication in prion diseases","volume":"127","author":"Zaccagnini","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejmech.2015.12.044","article-title":"Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity","volume":"109","author":"Di Capua","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib50","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/acs.jnatprod.5b00875","article-title":"Verbascoside inhibits promastigote growth and arginase activity of leishmania amazonensis","volume":"79","author":"Maquiaveli","year":"2016","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2020.112405_bib51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejmech.2018.07.069","article-title":"Novel spiroindoline HDAC inhibitors: synthesis, molecular modelling and biological studies","volume":"157","author":"Brindisi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib52","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejmech.2018.03.024","article-title":"Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analog","volume":"150","author":"Vallone","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib53","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4155\/fmc-2016-0068","article-title":"Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies","volume":"8","author":"Brindisi","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib54","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1021\/acs.jmedchem.8b00099","article-title":"(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid (AMPA) and kainate receptor ligands: further exploration of bioisosteric replacements and structural and biological investigation","volume":"61","author":"Brogi","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112405_bib55","doi-asserted-by":"crossref","first-page":"115045","DOI":"10.1016\/j.bmc.2019.115045","article-title":"Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold","volume":"27","author":"Reale","year":"2019","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420303767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420303767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:14:06Z","timestamp":1759328046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420303767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":55,"alternative-id":["S0223523420303767"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112405","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of 7-substituted 4-phenyl-6H-imidazo[1,5-a]thieno[3,2-f] [1,4]diazepines as safe anxiolytic agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112405"}}